< Back to latest news & events

News

Can the Chancellor’s so-called “Europe’s Silicon Valley” really replicate the innovative activity of its namesake?

February 2025

The Chancellor of the UK, Rachel Reeves, recently unveiled plans to deliver an Oxford-Cambridge growth corridor that promises to boost the UK economy by up to £78 billion by 2035.  Declaring the UK as being at the “forefront of some of the most exciting developments in the world like artificial intelligence and life sciences”, she saw the 66 miles between Oxford and Cambridge as the “home of British innovation”, “with ingredients to replicate the success of Silicon Valley or the Boston Cluster”.

But how realistic are the Chancellor’s plans?

It’s relatively rare for the worlds of politics and Intellectual Property (IP) to collide. However, IP and, in particular, patent filings are often used as a barometer for innovation. As a rough and ready gauge of the Chancellor’s ambition, we’ve taken a look at how many artificial intelligence (AI) and life science (LS) patents have been filed by applicants in innovation hubs in Oxfordshire and Cambridgeshire and compared these numbers to those filed in the Silicon Valley and Boston Cluster.

A snapshot of our findings are summarised in the graphs below:

Data from IP Pilot; IPC codes: G06N and T

Data from IP Pilot; IPC codes: C12M, N, P, Q and R, A61K

Admittedly, these statistics are raw. Inaccuracies will arise for a variety of reasons. For example, if a patent for research carried out in e.g., Cambridge is filed in the name of a company registered elsewhere, our analysis will not have picked this up. Accordingly, the statistics must be taken with a large pinch of salt. Coupled with the differences in population between the areas compared, it’s clear that they do not provide an accurate comparison.

Nonetheless, the differences between the US and UK filing numbers are so great that it’s probably safe to say that the new growth corridor has a significant amount of catching up to do at least insofar as patenting in AI and LS is concerned. That said, the dominance of Silicon Valley and the Boston Cluster is hardly surprising as they’ve been well-funded and well-established hubs of innovation for a very long time.

Silicon Valley, for example, can trace its roots to an electrical company started in a garage by Standford alumni, William Hewlett and David Packard, in 1938[1].  Similarly, the Boston cluster can trace its roots to the late 1970s and early 80s, when Biogen and Genzyme were founded by scientists from nearby academic institutions[2]. So, in this context, the US has history on its side. Nonetheless, with the Chancellor’s promise to go “further and faster” to drive growth, the UK has the potential to improve its impact in the AI and LS fields. In any event, as we all know, numbers –particularly patent filing numbers – never tell the whole story and, as the old adage goes, quality always trumps quantity.

So what can the UK do to ensure that quality innovation boosts the economy in the manner we hope. Readers old enough to recall the VHS-Betamax[3] debate will know that it’s rarely the quality of the technology alone that will guarantee commercial success. Strategies need to be in place to ensure that technology successfully makes its journey to market. Here is where IP comes in. IP protection provides researchers with a period of exclusivity to get ahead of the competition. A 2023 study reported by the European Patent Office (EPO) found that start-ups with patents and trademarks were 10 times more successful in securing funding. The exclusivity afforded by IP protection will be attractive to investors, who will want to reap the rewards of their investment in a less competitive environment for at least a period of time. IP can also spur innovation, encouraging competitors to seek improvements and/or design-arounds to their competitor’s IP to enable them to customers a variety of technical solutions in the same space. Developing strategies to best protect innovation will be key to getting technology from the lab or “virtual” bench to market.

So if the Chancellor really wants to go “further and faster” to kick start the economy, it’s not just the much-touted transport links between Oxford and Cambridge that she needs to worry about. We need an ecosystem around the hubs of innovation to ensure that companies are supported to convert great science to tangible commercial results. Protecting intangible assets through IP will a key role in this.


This article was prepared by Hsu Min Chung (Partner, Chemistry & Materials), Craig Thomson (Partner, Life Sciences), Kerry Rees (Partner, Life Sciences) and Matt Cassie (Partner, AI)

[1] https://www.hp.com/hpinfo/abouthp/histnfacts/publications/garage/innovation.pdf

[2] https://www.economist.com/business/2016/01/16/clusterluck

[3] https://www.cgchomevideo.com/en-US/news-and-events/news/76/the-case-of-betamax-versus-vhs

Latest updates

HGF Director Promotions

We are pleased to announce a number of director promotions that will take effect from 1st December 2025. These individuals have demonstrated exceptional expertise, commitment, and leadership within their respective …

Read article

UK IPO fees to increase from 1 April 2026

Whilst the fee changes are subject to parliamentary approval, they are almost certain to take effect – read on to learn more. The United Kingdom Intellectual Property Office (UK IPO) …

Read article

Mycelium Meets Market Reality: The Quiet Role of IP in Scaling Sustainable Materials

Fungal materials are increasingly used in applications ranging from sustainable packaging and leather alternatives to construction composites, textiles, and biotechnology. These developments are transforming fungi from a niche research subject …

Read article
Event - 24th - 25th November 2025

HGF Partners with 3AF for the P2I2025 Symposium

HGF are pleased to be a partner of P2I2025, the annual symposium organised by the Intellectual Property Commission of the French Aeronautics and Astronautics Association (3AF). The event brings together …

Event details

Retailers liability and AI Applications

The question of whether the user (consumer) or the provider of an AI application is liable for the infringement of intellectual property rights as a result of the use of …

Read article
Event - 11th November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Event details

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Read article

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Read article